Real‐world experience of ocrelizumab in multiple sclerosis in a Spanish population

by Eva Fernandez‐Diaz, Jose A. Perez‐Vicente, Ramon Villaverde‐Gonzalez, Leticia Berenguer‐Ruiz, Antonio Candeliere Merlicco, Maria Luisa Martinez‐Navarro, Julia Gracia Gil, Carlos M. Romero‐Sanchez, Arantxa Alfaro‐Saez, Inmaculada Diaz, Juana Gimenez‐Martinez, Maria Angeles Mendez‐Miralles, Jorge Millan‐Pascual, Javier Jimenez‐Pancho, Santiago Mola, Angel P. Sempere
Published 2021-02-01